⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Alderys and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Alderys
↗Orsay, France
Alderys is a French biotechnology company that develops innovative biological engineering approaches to produce chemical compounds from renewable plant resources. The company utilizes proprietary genome engineering platforms, such as G-DESIGNER, to modify yeast strains (Saccharomyces cerevisiae) for the production of valuable compounds used in the chemical, cosmetic, and animal nutrition industries.
Since July 2020, Alderys has operated as a subsidiary of Givaudan, the global leader in flavors and fragrances. The acquisition was part of Givaudan's long-term strategy to expand its capabilities in bio-engineering, natural ingredients, and sustainable, bio-sourced product development.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Industrial Biotechnology / Synthetic Biology
SIZE & FINANCIALS
Employees:1-50
Founded:2009
Ownership:subsidiary
Status:acquired
STOCK
Exchange:SIX Swiss Exchange
Ticker:GIVN
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A
Modalities:Synthetic Biology, Metabolic Engineering
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Givaudan
Acquired By:Givaudan (2020-07-01)
Key Partnerships:Givaudan (Parent), Michelin (via BioImpulse project for bio-based adhesives), ARD (Vivescia group, for industrial scale-up)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Dominique Thomas - CEO
LINKS
Website:alderys.fr
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Alderys. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.